Dr. Wentzensen is Senior Investigator, and Deputy Chief of the Clinical Genetics Branch and Head of the Clinical Epidemiology Unit, in the Division of Cancer Epidemiology and Genetics (DCEG), at the National Cancer Institute. He earned his MD and PhD at the University of Heidelberg and a Master of Epidemiology from the University of Mainz. Dr. Wentzensen is an international expert in molecular and clinical epidemiology of gynecological cancers with a focus on cervical disease detection and the identification and validation of novel biomarkers for translation into new prevention methods. He is co-principal investigator of the NCI Moonshot Project to Accelerate Cervical Cancer Control.


He regularly serves as an expert on national and international committees focused on gynecological and other cancers, including the 2019 ASCCP Risk-Based Management Consensus Guidelines. He chairs the Enduring Cervical Cancer Screening and Management Guidelines effort to regularly update recommendations as new technologies are approved for clinical use. He recently co-chaired a cervical cancer screening working group for the President’s Cancer Panel and he led an update of the cervical cancer screening handbook for the International Agency for Research on Cancer, part of the World Health Organization (WHO). He also plays a major role in the ongoing development of the new WHO cervical cancer screening guidelines.